DENTSPLY SIRONA Inc. $XRAY Shares Sold by Quantbot Technologies LP

Quantbot Technologies LP reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 55.7% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 182,425 shares of the medical instruments supplier’s stock after selling 229,551 shares during the quarter. Quantbot Technologies LP’s holdings in DENTSPLY SIRONA were worth $2,897,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Public Employees Retirement System of Ohio lifted its holdings in shares of DENTSPLY SIRONA by 1.4% in the second quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock valued at $983,000 after buying an additional 861 shares during the period. Gabelli Funds LLC grew its holdings in DENTSPLY SIRONA by 1.0% during the first quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock worth $1,464,000 after acquiring an additional 1,000 shares during the period. AlphaQuest LLC raised its position in DENTSPLY SIRONA by 2.5% in the second quarter. AlphaQuest LLC now owns 52,817 shares of the medical instruments supplier’s stock worth $839,000 after acquiring an additional 1,294 shares in the last quarter. Empowered Funds LLC lifted its holdings in DENTSPLY SIRONA by 8.8% in the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 1,320 shares during the last quarter. Finally, Covestor Ltd boosted its position in shares of DENTSPLY SIRONA by 17.5% during the 1st quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier’s stock valued at $146,000 after purchasing an additional 1,456 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

XRAY has been the topic of a number of research reports. Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Friday, November 7th. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Zacks Research cut DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Finally, Mizuho set a $13.00 price objective on DENTSPLY SIRONA in a research note on Friday, November 7th. Two analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $16.08.

DENTSPLY SIRONA Stock Down 0.6%

XRAY stock opened at $11.27 on Friday. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The firm has a market capitalization of $2.25 billion, a P/E ratio of -2.55, a P/E/G ratio of 0.83 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 52-week low of $9.85 and a 52-week high of $20.59. The company’s 50 day simple moving average is $11.92 and its 200-day simple moving average is $13.97.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The firm had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. During the same quarter in the previous year, the firm posted $0.50 earnings per share. The company’s revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.